AVESTA
  • About
  • Focus Areas
  • Research
  • Knowledge
  • News
  • Team
Get Involved
Enhancing carboplatin sensitivity in ovarian cancer cells by blocking the mercapturic acid pathway transporter
Carcinogenesis
Home / Knowledge Hub / Publications / Enhancing carboplatin sensitivity in ovarian cancer cells by blocking the mercapturic acid pathway transporter
← Previous Next →
Carcinogenesis

Enhancing carboplatin sensitivity in ovarian cancer cells by blocking the mercapturic acid pathway transporter

Shows that blocking RLIP76 increases the sensitivity of ovarian cancer cells to carboplatin.

July 2024
1 min read
2 views
Share in 𝕏 ✉
← Previous Next →

Related Articles

Rlip depletion prevents spontaneous neoplasia in TP53 null mice
PNAS
Rlip depletion prevents spontaneous neoplasia in TP53 null mice
A Central Role of RLIP76 in Regulation of Glycemic Control
Diabetes
A Central Role of RLIP76 in Regulation of Glycemic Control
RLIP depletion suppresses ovarian cancer growth and metastasis
Journal of Ovarian Research
RLIP depletion suppresses ovarian cancer growth and metastasis
avesta-logo

Avesta Bio advances science-driven healthcare innovation, improving patient outcomes through evidence, ethics, and an unwavering commitment to human dignity.

in

About

  • Who We Are
  • Our Foundation
  • Focus Areas
  • Our Journey
  • Team

Research

  • RLIP76 Research
  • Publications
  • White Papers
  • Advisor Insights

Connect

  • News
  • Contact Us
  • Partner With Us
  • Philanthropic Giving

© 2026 Avesta Bio. All rights reserved.

  • Privacy Policy
  • Terms of Use